These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1012 related items for PubMed ID: 15777980

  • 1. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
    Lena MD, Ramlau R, Hansen O, Lorusso V, Wagner L, Barni S, Cristovao MM, Huber R, Alberola V, Mitrovic M, Colin C, Gasmi J.
    Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
    Reck M, Macha HN, Del Barco S, Cornes P, Vaissière N, Morand M, Riggi M, Abratt R.
    Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
    [Abstract] [Full Text] [Related]

  • 3. A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma.
    Chen YM, Yu CJ, Yang CH, Perng RP, Tsai CM, Shih JF, Cheng AL, Lefresne F, Barbier M, Pouget JC, Yang PC.
    Lung Cancer; 2007 Apr; 56(1):89-95. PubMed ID: 17208330
    [Abstract] [Full Text] [Related]

  • 4. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P, Ciuleanu TE, Cernea D, Pelau D, Gaal V, Cebotaru C, Guttman T, Todor N, Ghilezan N.
    J BUON; 2007 Apr; 12(1):33-9. PubMed ID: 17436399
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of a biweekly regimen of vinorelbine and cisplatin in advanced non-small cell lung cancer.
    Chen CH, Lin CM, Kao KC, Chang JW, Tsao TC.
    Chang Gung Med J; 2007 Apr; 30(3):249-55. PubMed ID: 17760276
    [Abstract] [Full Text] [Related]

  • 6. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T, Pujol JL, Douillard JY, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Besson F.
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [Abstract] [Full Text] [Related]

  • 7. Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC).
    Pereira JR, Martins SJ, Nikaedo SM, Ikari FK.
    BMC Cancer; 2004 Sep 29; 4():69. PubMed ID: 15456520
    [Abstract] [Full Text] [Related]

  • 8. Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: a phase II study.
    Martoni AA, Melotti B, Sperandi F, Giaquinta S, Piana E, Pavesi L, Da Prada G, Lelli G.
    Lung Cancer; 2008 Jun 29; 60(3):387-92. PubMed ID: 18160123
    [Abstract] [Full Text] [Related]

  • 9. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P, Petruzelka L, Zemanova M, Havel L, Janku F, Judas L, Kubik A, Krepela E, Fiala P, Pecen L.
    Lung Cancer; 2004 Oct 29; 46(1):87-98. PubMed ID: 15364136
    [Abstract] [Full Text] [Related]

  • 10. A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly.
    Chen YM, Perng RP, Shih JF, Whang-Peng J.
    Lung Cancer; 2008 Aug 29; 61(2):214-9. PubMed ID: 18243407
    [Abstract] [Full Text] [Related]

  • 11. Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study.
    Cigolari S, Curcio C, Maiorino A, Sessa R, Cioffi A, Massimo M.
    Anticancer Res; 2003 Aug 29; 23(2C):1803-9. PubMed ID: 12820462
    [Abstract] [Full Text] [Related]

  • 12. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R, Zatloukal P, Jassem J, Schwarzenberger P, Orlov SV, Gottfried M, Pereira JR, Temperley G, Negro-Vilar R, Rahal S, Zhang JK, Negro-Vilar A, Dziewanowska ZE.
    J Clin Oncol; 2008 Apr 10; 26(11):1886-92. PubMed ID: 18398154
    [Abstract] [Full Text] [Related]

  • 13. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE.
    Cancer J Sci Am; 1995 Apr 10; 1(4):288-94. PubMed ID: 9166490
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V, Galetta D, Lorusso V, Caruso M, Verderame F, Pezzella G, Borsellino N, Durini E, Valenza R, Agostara B, Colucci G, Gruppo Oncologico Italia Meridionale.
    Lung Cancer; 2008 Sep 10; 61(3):369-77. PubMed ID: 18308419
    [Abstract] [Full Text] [Related]

  • 15. A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated.
    Chen YM, Perng RP, Shih JF, Tsai CM, Whang-Peng J.
    Lung Cancer; 2005 Mar 10; 47(3):373-80. PubMed ID: 15713520
    [Abstract] [Full Text] [Related]

  • 16. Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer.
    Mori K, Kamiyama Y, Kondo T, Kano Y, Tominaga K.
    Cancer Chemother Pharmacol; 2004 Feb 10; 53(2):129-32. PubMed ID: 14605861
    [Abstract] [Full Text] [Related]

  • 17. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P.
    Semin Oncol; 2000 Feb 10; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [Abstract] [Full Text] [Related]

  • 18. Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen. A phase II study.
    Tummarello D, Graziano F, Isidori P, Santo A, Cetto G, Fedeli A, Rossi G, Cellerino R.
    Cancer; 1996 Jun 01; 77(11):2251-7. PubMed ID: 8635092
    [Abstract] [Full Text] [Related]

  • 19. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.
    Hirose T, Mizutani Y, Ohmori T, Ishida H, Hosaka T, Ando K, Shirai T, Okuda K, Ohnishi T, Horichi N, Kubota H, Adachi M.
    Cancer Chemother Pharmacol; 2006 Sep 01; 58(3):361-7. PubMed ID: 16331494
    [Abstract] [Full Text] [Related]

  • 20. A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer.
    Pallis AG, Agelidou A, Papakotoulas P, Tsaroucha A, Agelidou M, Agelaki S, Androulakis N, Vamvakas L, Gerogianni A, Kotsakis A, Kentepozidis N, Georgoulias V.
    Lung Cancer; 2006 May 01; 52(2):165-71. PubMed ID: 16563559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.